Health8 hours ago
Akebia Ends Vafseo Trials for Non-Dialysis Patients Following FDA Setback
Akebia Therapeutics has announced it will discontinue its efforts to expand the use of Vafseo (vadadustat) for treating anemia in patients with chronic kidney disease (CKD)...